Chronic Cyclosporine Nephrotoxicity: New Insights and Preventive Strategices

참고문헌 (98)

1. "The UNOS Scientific Renal Transplant Registry-1991", pp.1~11 (1991)
2. "Do we know the site of action of cyclosporin?", 13, pp.487~490 (1992)
3. "Immunosuppressants: cellular and molecular mechanisms of action", 28, pp.159~172 (1996)
4. "Optimizing the use of cyclosporine in renal transplantation", 28, pp.195~211 (1995)
5. "Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies", 7, pp.384~389 (2001)
6. "Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future", 35, pp.333~346 (2000)
7. "Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy", 65, pp.661~667 (1998)
8. "The long-term course of cyclosporine-associated chronic nephropathy", 33, pp.590~600 (1988)
9. "Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy", 48, pp.431~438 (1995)
10. "Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity", 48, pp.439~448 (1995)
11. "Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol", 92, pp.685~692 (2002)
12. "Cyclosporine A nephrotoxicity: role of thromboxane and reactive oxygen species", 131, pp.63~70 (1998)
13. "Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity", 71, pp.331~334 (2001)
14. "Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity", 66, pp.1325~1329 (1998)
15. "Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril", 269, pp.F491~499 (1995)
16. "Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells", 22, pp.189~193 (2003)
17. "Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats", 8, pp.161~172 (2000)
18. "The role of renal sympathetic nerves in experimental chronic cyclosporine nephropathy", 69, pp.2149~2153 (2000), 1
19. "Interaction of cyclosporine A and the renin- angiotensin system; new perspectives", 3, pp.61~71 (2002)
20. "Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney", 60, pp.847~857 (2001)
21. "Chronic cyclosporine- induced nephropathy in the rat. A medullary ray and inner stripe injury", 49, pp.445~452 (1990)
22. "Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake", 4, pp.214~221 (1993)
23. "Hyperuricemia exacerbates chronic cyclosporine nephropathy", 71, pp.900~905 (2001)
24. "Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy", 75, pp.309~315 (2003)
25. "Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats", 63, pp.454~463 (2003)
26. "Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin", 6, pp.1186~1196 (1995)
27. "Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy", 52, pp.660~673 (1997)
28. "Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis", 53, pp.897~908 (1998)
29. "Biosynthesis and homeostatic roles of nitric oxide in the normal kidney", 272, pp.F561~578 (1997)
30. "Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat", 2, pp.1291~1297 (1992)
31. "Diminished acetylcholine-induced vasodilation in renal microvessels of cyclosporine-treated rats", 3, pp.42~50 (1992)
32. "Cyclosporin A increases nitric oxide activity in vivo", 29, pp.570~575 (1997)
33. "Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression", 274, pp.F791~798 (1998)
34. "Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats", 6, pp.50~56 (1998)
35. "Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity", 63, pp.522~533 (2003)
36. "Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity", 58, pp.1174~1185 (2000)
37. "Structural and functional domains of osteopontin", 760, pp.6~11 (1995)
38. "Osteopontin expression and distribution in human carcinomas", 145, pp.610~623 (1994)
39. "Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR)", 177, pp.867~873 (1991)
40. "Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli", 69, pp.355~363 (1993)
41. "Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection", 170, pp.145~161 (1989)
42. "Osteopontin expression in fetal and mature human kidney", 10, pp.444~457 (1999)
43. "Osteopontin expression in cardiovascular diseases", 760, pp.109~126 (1995)
44. "Receptor- ligand interaction between CD44 and osteopontin (Eta-1)", 271, pp.509~512 (1996)
45. "A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5", 270, pp.26232~26238 (1995)
46. "Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo", 171, pp.1931~1942 (1990)
47. "Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis", 56, pp.571~580 (1999)
48. "Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin)", 144, pp.915~926 (1994)
49. "Osteopontin in chronic puromycin aminonucleoside nephrosis", 8, pp.1383~1390 (1997)
50. "Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis", 28, pp.139~150 (1998)
51. "Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II", 58, pp.1469~1480 (2000)
52. "Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity", 92, pp.422~430 (2002)
53. "Effects of cyclosporine in osteopontin null mice", 62, pp.78~85 (2002)
54. "Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy", 30, pp.71~81 (1997)
55. "Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity", 2, pp.111~119 (2002)
56. "Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation", 14, pp.377~388 (2003)
57. "The transforming growth factor-beta system and the kidney", 13, pp.116~128 (1993)
58. "Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1", 270, pp.7304~7310 (1995)
59. "Activation of the bone-derived latent TGF beta complex by isolated osteoclasts", 158, pp.817~823 (1989)
60. "Negative regulation of transforming growth factor-beta by the proteoglycan decorin", 346, pp.281~284 (1990)
61. "Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin", 262, pp.14090~14099 (1987)
62. "cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta", 11, pp.511~a522 (1992)
63. "The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin", 277, pp.28003~28009 (2002)
64. "Immunohistochemical and ultrastructural localization of MP78", 70 (betaig-h3) in extracellular matrix of developing and mature bovine tissues, 1997, pp.45, 1683~1696
65. "Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells", 79, pp.261~273 (2000)
66. "Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions", 16, pp.576~584 (1996)
67. "Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy", 72, pp.1826~1829 (2001)
68. "Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney", 143, pp.175~183 (2004)
69. "Role and regulation of apoptotic cell death in the kidney. Y2K update", 5, pp.D735~749 (2000)
70. "Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity", 139, pp.364~371 (2002)
71. "Cyclosporin A, apoptosis of BAL T-cells and expression of Bcl-2 in asthmatics", 22, pp.207~212 (2003)
72. "Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases", 68, pp.S25~29 (1998)
73. "Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line", 54, pp.1955~1966 (1998)
74. "Expression of apoptosis- related genes in chronic cyclosporine nephrotoxicity in mice", 2, pp.391~399 (2002)
75. "Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis", 56, pp.2147~2159 (1999)
76. "Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal", 25, pp.401~411 (2004)
77. "Nitric oxide mediates cyclosporine- induced apoptosis in cultured renal cells", 57, pp.1549~1559 (2000)
78. "Transcription factor-kappa B (NF- kappa B) and renal disease", 59, pp.415~424 (2001)
79. "Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis", 161, pp.430~439 (1998)
80. "Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease", 60, pp.1366~1377 (2001)
81. "The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease", 75, pp.S7~14 (2000)
82. "Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation", 75, pp.1040~1044 (2003)
83. "HSP70 as endogenous stimulus of the Toll", interleukin-1 receptor signal pathway, 2002, pp.277, 15107~151412
84. "Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins", 73, pp.574~583 (2003)
85. "Water channels and urea transporters", 24, pp.1~9 (1997)
86. "Physiology and pathophysiology of renal aquaporins", 10, pp.647~663 (1999)
87. "Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria", 58, pp.701~711 (2000)
88. "Aquaporins in the kidney: from molecules to medicine", 82, pp.205~244 (2002)
89. "Regulation of renal urea transporters", 10, pp.635~646 (1999)
90. "97- and 117-kDa forms of collecting duct urea transporter UT-A1 are due to different states of glycosylation", 281, pp.F133~43 (2001)
91. "UT-A3: localization and characterization of an additional urea transporter isoform in the IMCD", 280, pp.F325~332 (2001)
92. "Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues", 281, pp.C1318~1325 (2001)
93. "UT-A2: a 55-kDa urea transporter in thin descending limb whose abundance is regulated by vasopressin", 278, pp.F52~62 (2000)
94. "Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney", 287, pp.F139~151 (2004)
95. "Renal calcium metabolism and diuretics", 26, pp.101~116 (1986)
96. "Physiology and biochemistry of vitamin D-dependent calcium binding proteins", 259, pp.F195~209 (1990)
97. "Calcium-binding protein from human small intestine. Purification and characterization of a 10,000 molecular weight protein", 16, pp.468~472 (1986)
98. "Localization ofthe vitamin D-dependent calcium-binding protein in mammalian kidney", 243, pp.F243~252 (1982)

관련 논문AI추천